Optas, LLC Astrazeneca PLC Transaction History

Optas, LLC

$429 Million
Q3 2024

A detailed history of Optas, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Optas, LLC holds 15,570 shares of AZN stock, worth $1.04 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

15,570

Previous 5,693 173.49%

Holding current value

$1.04 Million

Previous $443,000 173.81%

% of portfolio

0.28%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$76.67 - $87.62 $757,269 - $865,422	9,877 Added 173.49%	15,570 $1.21 Million
Q2 2024 Jul 25, 2024	BUY	$66.81 - $80.83 $89,859 - $108,716	1,345 Added 30.93%	5,693 $443,000
Q1 2024 Apr 17, 2024	SELL	$61.03 - $69.57 $45,040 - $51,342	-738 Reduced 14.51%	4,348 $294,000
Q4 2023 Jan 25, 2024	BUY	$61.89 - $69.28 $25,870 - $28,959	418 Added 8.95%	5,086 $342,000
Q3 2023 Oct 31, 2023	BUY	$64.85 - $71.7 $34,111 - $37,714	526 Added 12.7%	4,668 $316,000
Q2 2023 Jul 20, 2023	BUY	$69.91 - $75.81 $22,161 - $24,031	317 Added 8.29%	4,142 $296,000
Q1 2023 Apr 17, 2023	SELL	$63.15 - $71.6 $13,893 - $15,751	-220 Reduced 5.44%	3,825 $265,000
Q4 2022 Jan 27, 2023	SELL	$54.21 - $70.44 $21,412 - $27,823	-395 Reduced 8.9%	4,045 $274,000
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $46,233 - $118,374	872 Added 24.44%	4,440 $242,000
Q2 2022 Aug 01, 2022	BUY	$59.26 - $71.14 $28,207 - $33,862	476 Added 15.39%	3,568 $236,000
Q1 2022 Apr 26, 2022	SELL	$55.72 - $67.12 $18,443 - $22,216	-331 Reduced 9.67%	3,092 $205,000
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $184,910 - $218,490	3,423 New	3,423 $200,000
Q4 2020 Jan 27, 2021	SELL	$48.52 - $58.02 $242,939 - $290,506	-5,007 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$53.07 - $61.1 $265,721 - $305,927	5,007 New	5,007 $275,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.

Account